real-time news and commentary for investors
Monday, Jul 9
2012, 10:02 AM
Questcor Pharmaceuticals (QCOR +10.1%) jumps after releasing June prescription data for its...
Questcor Pharmaceuticals (QCOR +10.1%) jumps after releasing June prescription data for its Acthar gel. Paid Acthar prescriptions for treating nephrotic syndrome rose to 115-120 in June from 103 in May, prescriptions for treating multiple sclerosis rose to 400-410 from 365, and prescriptions for treating infantile spasms came in at 30-35, compared with 32 in May. It's added Questcor repurchased $156.1M worth of shares in Q2 at an average price of $41.85.